Dong Hui Yang
Fondateur chez Hangzhou Adlai Nortye Biopharma Co. Ltd.
Profil
Dong Hui Yang was the founder of Hangzhou Adlai Nortye Biopharma Co. Ltd.
which was founded in 2004, where he held the title of Executive Director & Senior Vice President.
He also held the title of Executive Director & Senior Vice President at Adlai Nortye Ltd.
in a former job.
Mr. Yang received his graduate degree from South China Normal University in 2002 and his undergraduate degree from Jiangxi Normal University in 1999.
Postes actifs de Dong Hui Yang
| Sociétés | Poste | Début |
|---|---|---|
Hangzhou Adlai Nortye Biopharma Co. Ltd.
 Hangzhou Adlai Nortye Biopharma Co. Ltd. BiotechnologyHealth Technology Part of Adlai Nortye Ltd., Hangzhou Adlai Nortye Biopharma Co. Ltd. is a clinical-stage biopharmaceutical company based in Hangzhou, China. Adlai Nortye is developing differentiated, innovative immuno-oncology medicines with a focus on discovering and developing important new treatments for cancer. The Chinese company's mission is to improve patient lives by identifying and developing differentiated innovative medicines that help people live better and longer. The company was founded in 2004 by Yang Lu, Dong Hui Yang, and Yang Lu has been the CEO since then. | Fondateur | 01/01/2004 |
Anciens postes connus de Dong Hui Yang
| Sociétés | Poste | Fin |
|---|---|---|
| ADLAI NORTYE LTD. | Directeur/Membre du Conseil | - |
Formation de Dong Hui Yang
| South China Normal University | Graduate Degree |
| Jiangxi Normal University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ADLAI NORTYE LTD. | Commercial Services |
| Entreprise privées | 1 |
|---|---|
Hangzhou Adlai Nortye Biopharma Co. Ltd.
Hangzhou Adlai Nortye Biopharma Co. Ltd. BiotechnologyHealth Technology Part of Adlai Nortye Ltd., Hangzhou Adlai Nortye Biopharma Co. Ltd. is a clinical-stage biopharmaceutical company based in Hangzhou, China. Adlai Nortye is developing differentiated, innovative immuno-oncology medicines with a focus on discovering and developing important new treatments for cancer. The Chinese company's mission is to improve patient lives by identifying and developing differentiated innovative medicines that help people live better and longer. The company was founded in 2004 by Yang Lu, Dong Hui Yang, and Yang Lu has been the CEO since then. | Health Technology |